JP Stock MarketDetailed Quotes

4572 Carna Biosciences

Watchlist
  • 304
  • -7-2.25%
20min DelayTrading Dec 16 13:23 JST
5.81BMarket Cap-4.43P/E (Static)

Carna Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-50.74%134.77M
-20.31%180.87M
17.24%1.63B
214.14%914.6M
-17.71%210.72M
-3.96%273.6M
-59.08%226.97M
-31.27%1.39B
-78.92%291.14M
24.00%256.06M
Cost of revenue
5.61%35.96M
-4.04%46.67M
2.18%175.29M
7.88%51.65M
0.90%40.96M
-16.13%34.05M
14.48%48.64M
26.71%171.55M
20.92%47.88M
51.76%40.6M
Gross profit
-58.75%98.81M
-24.75%134.2M
19.37%1.45B
254.73%862.95M
-21.21%169.76M
-1.94%239.55M
-65.18%178.33M
-35.44%1.22B
-81.87%243.27M
19.87%215.47M
Operating expense
30.15%777.57M
-19.54%550.44M
3.32%2.57B
2.46%778.17M
-22.72%507.82M
7.18%597.46M
33.87%684.13M
2.98%2.49B
7.95%759.45M
15.00%657.16M
Operating profit
-89.65%-678.76M
17.71%-416.24M
12.04%-1.12B
116.42%84.78M
23.46%-338.06M
-14.29%-357.9M
-44,663.26%-505.79M
-139.09%-1.27B
-180.92%-516.18M
-12.77%-441.69M
Net non-operating interest income (expenses)
-2,019.17%-23.88M
129.19%1.59M
36.31%-8.5M
86.61%-1.04M
22.79%-884K
49.42%-1.13M
-146.38%-5.45M
1.40%-13.35M
-384.15%-7.76M
88.06%-1.15M
Non-operating interest income
30.00%26K
3,832.81%2.52M
15.65%170K
25.00%25K
-12.86%61K
53.85%20K
45.45%64K
37.38%147K
17.65%20K
112.12%70K
Non-operating interest expense
0.13%800K
3.35%926K
-35.01%3.45M
3.10%1.06M
-43.05%692K
-44.09%799K
-45.17%896K
35.29%5.31M
22.27%1.03M
36.98%1.22M
Total other finance cost
----
----
-36.22%5.22M
--0
--253K
-57.14%348K
642.44%4.62M
-15.80%8.18M
769.72%6.75M
--0
Net investment income
85.69%7.71M
1,159.21%20.23M
-123.21%-288K
65.37%-6.62M
-66.55%4.09M
-8.35%4.15M
-153.14%-1.91M
-91.63%1.24M
-237.22%-19.11M
285.50%12.23M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
-209.58%-1.62M
-465.37%-2.61M
89.30%-4.56M
0
-3,038.60%-3.58M
98.23%-522K
96.57%-462K
-348.31%-42.62M
112.97%441K
-114K
Less:Other special charges
----
----
----
----
----
----
----
---1.96M
----
----
Less:Write off
209.58%1.62M
465.37%2.61M
-89.77%4.56M
--0
3,038.60%3.58M
-98.11%522K
-97.00%462K
368.90%44.58M
-55.40%1.52M
--114K
Other non-operating income (expenses)
1,548.41%2.27M
64.35%-77K
-142.48%-517K
96.92%-67K
-105.17%-77K
-108.96%-157K
-242.11%-216K
-82.25%1.22M
-57.18%-2.18M
47.67%1.49M
Income before tax
-95.26%-694.28M
22.72%-397.11M
14.55%-1.13B
114.14%77.05M
21.14%-338.51M
-5.02%-355.56M
-4,653.73%-513.83M
-148.53%-1.32B
-184.41%-544.79M
-8.10%-429.23M
Income tax
-91.24%950K
-66.85%1.78M
-15.65%22.05M
-104.17%-397K
-9.39%6.23M
99.08%10.84M
25.22%5.38M
1,223.54%26.14M
422.37%9.53M
52.10%6.87M
Net income
-89.75%-695.23M
23.17%-398.89M
14.57%-1.15B
113.97%77.45M
20.95%-344.74M
-6.51%-366.4M
-3,337.57%-519.21M
-152.50%-1.35B
-186.13%-554.32M
-8.59%-436.1M
Net income continuous operations
-89.75%-695.23M
23.17%-398.89M
14.57%-1.15B
113.97%77.45M
20.95%-344.74M
-6.51%-366.4M
-3,337.56%-519.21M
-152.50%-1.35B
-186.13%-554.32M
-8.59%-436.1M
Noncontrolling interests
Net income attributable to the company
-89.75%-695.23M
23.17%-398.89M
14.57%-1.15B
113.97%77.45M
20.95%-344.74M
-6.51%-366.4M
-3,337.57%-519.21M
-152.50%-1.35B
-186.13%-554.32M
-8.59%-436.1M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-89.75%-695.23M
23.17%-398.89M
14.57%-1.15B
113.97%77.45M
20.95%-344.74M
-6.51%-366.4M
-3,337.57%-519.21M
-152.50%-1.35B
-186.13%-554.32M
-8.59%-436.1M
Gross dividend payment
Basic earnings per share
-90.11%-39.98
29.01%-23.27
30.76%-68.62
112.63%5.12
37.78%-19.93
17.24%-21.03
-2,826.79%-32.78
-135.39%-99.1
-177.75%-40.54
-1.10%-32.03
Diluted earnings per share
-86.53%-39.98
29.01%-23.27
30.76%-68.62
111.14%4.5174
37.22%-20.1073
15.65%-21.4333
-2,826.79%-32.78
-135.39%-99.1
-183.83%-40.54
-1.10%-32.03
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -50.74%134.77M-20.31%180.87M17.24%1.63B214.14%914.6M-17.71%210.72M-3.96%273.6M-59.08%226.97M-31.27%1.39B-78.92%291.14M24.00%256.06M
Cost of revenue 5.61%35.96M-4.04%46.67M2.18%175.29M7.88%51.65M0.90%40.96M-16.13%34.05M14.48%48.64M26.71%171.55M20.92%47.88M51.76%40.6M
Gross profit -58.75%98.81M-24.75%134.2M19.37%1.45B254.73%862.95M-21.21%169.76M-1.94%239.55M-65.18%178.33M-35.44%1.22B-81.87%243.27M19.87%215.47M
Operating expense 30.15%777.57M-19.54%550.44M3.32%2.57B2.46%778.17M-22.72%507.82M7.18%597.46M33.87%684.13M2.98%2.49B7.95%759.45M15.00%657.16M
Operating profit -89.65%-678.76M17.71%-416.24M12.04%-1.12B116.42%84.78M23.46%-338.06M-14.29%-357.9M-44,663.26%-505.79M-139.09%-1.27B-180.92%-516.18M-12.77%-441.69M
Net non-operating interest income (expenses) -2,019.17%-23.88M129.19%1.59M36.31%-8.5M86.61%-1.04M22.79%-884K49.42%-1.13M-146.38%-5.45M1.40%-13.35M-384.15%-7.76M88.06%-1.15M
Non-operating interest income 30.00%26K3,832.81%2.52M15.65%170K25.00%25K-12.86%61K53.85%20K45.45%64K37.38%147K17.65%20K112.12%70K
Non-operating interest expense 0.13%800K3.35%926K-35.01%3.45M3.10%1.06M-43.05%692K-44.09%799K-45.17%896K35.29%5.31M22.27%1.03M36.98%1.22M
Total other finance cost ---------36.22%5.22M--0--253K-57.14%348K642.44%4.62M-15.80%8.18M769.72%6.75M--0
Net investment income 85.69%7.71M1,159.21%20.23M-123.21%-288K65.37%-6.62M-66.55%4.09M-8.35%4.15M-153.14%-1.91M-91.63%1.24M-237.22%-19.11M285.50%12.23M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) -209.58%-1.62M-465.37%-2.61M89.30%-4.56M0-3,038.60%-3.58M98.23%-522K96.57%-462K-348.31%-42.62M112.97%441K-114K
Less:Other special charges -------------------------------1.96M--------
Less:Write off 209.58%1.62M465.37%2.61M-89.77%4.56M--03,038.60%3.58M-98.11%522K-97.00%462K368.90%44.58M-55.40%1.52M--114K
Other non-operating income (expenses) 1,548.41%2.27M64.35%-77K-142.48%-517K96.92%-67K-105.17%-77K-108.96%-157K-242.11%-216K-82.25%1.22M-57.18%-2.18M47.67%1.49M
Income before tax -95.26%-694.28M22.72%-397.11M14.55%-1.13B114.14%77.05M21.14%-338.51M-5.02%-355.56M-4,653.73%-513.83M-148.53%-1.32B-184.41%-544.79M-8.10%-429.23M
Income tax -91.24%950K-66.85%1.78M-15.65%22.05M-104.17%-397K-9.39%6.23M99.08%10.84M25.22%5.38M1,223.54%26.14M422.37%9.53M52.10%6.87M
Net income -89.75%-695.23M23.17%-398.89M14.57%-1.15B113.97%77.45M20.95%-344.74M-6.51%-366.4M-3,337.57%-519.21M-152.50%-1.35B-186.13%-554.32M-8.59%-436.1M
Net income continuous operations -89.75%-695.23M23.17%-398.89M14.57%-1.15B113.97%77.45M20.95%-344.74M-6.51%-366.4M-3,337.56%-519.21M-152.50%-1.35B-186.13%-554.32M-8.59%-436.1M
Noncontrolling interests
Net income attributable to the company -89.75%-695.23M23.17%-398.89M14.57%-1.15B113.97%77.45M20.95%-344.74M-6.51%-366.4M-3,337.57%-519.21M-152.50%-1.35B-186.13%-554.32M-8.59%-436.1M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -89.75%-695.23M23.17%-398.89M14.57%-1.15B113.97%77.45M20.95%-344.74M-6.51%-366.4M-3,337.57%-519.21M-152.50%-1.35B-186.13%-554.32M-8.59%-436.1M
Gross dividend payment
Basic earnings per share -90.11%-39.9829.01%-23.2730.76%-68.62112.63%5.1237.78%-19.9317.24%-21.03-2,826.79%-32.78-135.39%-99.1-177.75%-40.54-1.10%-32.03
Diluted earnings per share -86.53%-39.9829.01%-23.2730.76%-68.62111.14%4.517437.22%-20.107315.65%-21.4333-2,826.79%-32.78-135.39%-99.1-183.83%-40.54-1.10%-32.03
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
D. Western Therapeutics Institute
4576
133 +27.88%
Wintest
6721
101 +26.25%
Ridge-i
5572
2682 +22.91%
River Eletec
6666
454 +21.39%
Heartseed
219A
2341 +20.61%

See the daily top gainer.